Will Ranbaxy sell its lipitor rights??

The most popular question among the analysts and trade specialists today is" Will Ranbaxy sell its Lipitor rights?"  After winning the rights for 180 day exclusivity of Lipitor  in U.S(2008), Ranbaxy was considered to be sitting on a cake of profits. Although citing regulatory reasons, FDA withdrew its approval of several manufacturing...

Read More

Sugar to fight against Hospital infections!!

A Carbohydrate found on the surface of one of the most virulent strains of Clostridium Difficile has been synthesized by scientists in Germany. This piece of research can prove to be an important breakthrough in the Vaccine development programme against the infection. C.Difficile bacterium C.Difficile is a species of Gram-positive bacteria of...

Read More

Schedule HX: A Proposed Solution to ever increasing problem of Antibiotic Resistance!!

No, we are not talking about any drug or a device that may help combat Antibiotic resistance, the extent of which has gone out of bounds due to the random popping of these pills by the people. What we are talking about is a new Schedule(HX), an amendment to the Drugs & Cosmetics Act,1945  proposed by the Union Health ministry in...

Read More

Setback for Teva Pharma as its MS drug laquinimod flunks in Ph3 Trials!!

Teva's late-stage oral MS drug laquinimod flunked the second of three Phase III studies, the latest in a series of disappointments. Researchers for Teva recruited more than 1,300 MS patients in 153 sites around the globe for the BRAVO study. They were randomized in two groups, with one getting laquinimod and the other receiving a placebo. According...

Read More